Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New orally active taxane, DJ-927, with a promising preclinical profile

April 11, 2002

Inhibitors of VEGF useful for cancer and rheumatoid arthritis described in AstraZeneca patents

April 10, 2002

Cdc25 inhibitor described at AACR meeting as warranting further evaluation as an anticancer agent

April 10, 2002

IDN-5390 as a novel taxane suitable for protracted administration

April 10, 2002

Taiho presents novel anticancer compounds that induce p300 gene expression

April 10, 2002

Selfadministration of new Endostatin formulation in clinical trials

April 10, 2002

Gene-based therapy EG-009 designated orphan drug for high-grade glioma

April 9, 2002

Streptomyces strain discovered to produce new antitumor compounds

April 9, 2002

Potent and selective uPA inhibitors designed by Corvas scientists

April 9, 2002

New vascular damaging agents in development at Angiogene Pharmaceuticals

April 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...